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AbstrACt
Introduction Approximately 400 000 Americans and 
36 000 Canadians undergo cardiac surgery annually, 
and up to 56% will develop chronic postsurgical pain 
(CPSP). The primary aim of this study is to explore 
the association of pain-related beliefs and gender-
based pain expectations on the development of CPSP. 
Secondary goals are to: (A) explore risk factors for 
poor functional status and patient-level cost of illness 
from a societal perspective up to 12 months following 
cardiac surgery; and (B) determine the impact of CPSP 
on quality-adjusted life years (QALYs) borne by cardiac 
surgery, in addition to the incremental cost for one 
additional QALY gained, among those who develop 
CPSP compared with those who do not.
Methods and analyses In this prospective cohort 
study, 1250 adults undergoing cardiac surgery, 
including coronary artery bypass grafting and open-
heart procedures, will be recruited over a 3-year period. 
Putative risk factors for CPSP will be captured prior to 
surgery, at postoperative day 3 (in hospital) and day 30 
(at home). Outcome data will be collected via telephone 
interview at 6-month and 12-month follow-up. We will 
employ generalised estimating equations to model the 
primary (CPSP) and secondary outcomes (function and 
cost) while adjusting for prespecified model covariates. 
QALYs will be estimated by converting data from the 
Short Form-12 (version 2) to a utility score.
Ethics and dissemination This protocol has been 
approved by the responsible bodies at each of the 
hospital sites, and study enrolment began May 2015. 
We will disseminate our results through CardiacPain.
Net, a web-based knowledge dissemination platform, 
presentation at international conferences and 
publications in scientific journals.
trial registration number NCT01842568.
IntroduCtIon 
Approximately 400 000 Americans and 
36 000 Canadians undergo cardiac surgery 
annually, and these numbers are expected 
to rise as the population ages.1–5 Despite 
the proven survival and symptom-related 
benefits of cardiac surgeries, mounting 
evidence suggests that chronic postsurgical 
pain (CPSP)—and related poor functional 
recovery—following these procedures are 
major clinical problems.6–31 Moreover, the 
strengths and limitations of this study
 ► This is a prospective, multisite study with a large 
cohort of cardiac surgery patients.
 ► One-year follow-up is compliant with Initiative for 
Methods, Measurement, and Pain Assessment in 
Clinical Trials recommendations to standardise tim-
ing of outcome assessment for prognostic studies of 
chronic postsurgical pain (CPSP).
 ► A robust analysis plan using generalised estimating 
equations will be used to model the primary analy-
sis: the association between pain-related beliefs and 
gender-based pain expectations with the develop-
ment of CPSP at 6 months and 1 year while adjusting 
for prespecified covariates.
 ► Assiduous follow-up procedures will be adhered to, 
which have been proven effective in prior prospec-
tive observational studies.
 ► There is reliance on pain and quality of life self-re-
port outcome measures; however, rigorous criteria 
to define CPSP will be applied, and valid and reliable 
instruments will be used.
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economic consequences of persistent pain and dysfunc-
tion remain uncertain. Identification of factors associated 
with the development of CPSP could facilitate efforts 
to improve outcomes among high-risk patients, yet the 
majority of putative risk factors examined to date are not 
tenably modifiable in the perioperative context. Three 
psychological factors that do show promise as modifi-
able, potential risk factors for CPSP include pain-related 
beliefs, gender-based pain expectations and somatic 
preoccupation and coping. The purpose of this study is 
to examine whether these factors are associated with tran-
sition to CPSP following cardiac surgery.
CPsP following cardiac surgery
Due to conceptual and methodological differences in 
the assessment of pain, and conflicting opinions about 
the duration of ‘chronicity’, there is no one accepted 
definition of CPSP.32 However, there is consensus among 
experts32–38 that CPSP should meet the minimum criteria, 
set forth by Macrae and Davies33 and others,34–40 as 
follows. It must: (A) have developed after the surgical 
procedure, (B) be different from pain experienced prior 
to the procedure, (C) not be caused by other factors (eg, 
cancer recurrence and chronic infection), (D) be present 
for at least 2–3 months and (E) interfere significantly with 
health-related quality of life.34–40
Open cardiac surgeries involve many pain-sensitive 
structures, as they require a median sternotomy, retrac-
tion of the ribs and invasion of muscles and visceral 
tissues. In coronary artery bypass surgery (CABG), the 
grafting procedure requires harvesting at several sites 
including, most commonly, the internal mammary artery 
(IMA). The manipulation and retraction of the sternum 
as well as the use of electrocautery to dissect the IMA 
from the chest wall may result in nerve damage that leads 
to intercostal neuralgia.41–44 The greater and lesser saphe-
nous veins are also used as grafts in CABG surgery and 
require significant leg incisions. These procedures may 
result in pain that can last for variable periods and may be 
inflammatory or neuropathic in nature. CPSP in cardiac 
surgery patients is often experienced in the thorax and 
legs but has also been described, to a lesser degree, in 
the shoulders, back and neck.10 12 45 The pathophysiolog-
ical pathways underlying CPSP are multifactorial. Tissue 
damage leads to release of high concentrations of brady-
kinin, adenosine, lactate and potassium in the periph-
eral microenvironment, thereby causing nociceptor 
activation.46 47 These mediators activate capsaicin-sensi-
tive TRVP1 receptors, which serve as the primary trans-
ducer of the noxious stimulus.47 Other neurochemicals, 
such as the neuropeptides substance P and calcitonin 
gene-related peptide, further augment pain.47 These 
peripheral nociceptive processes are modulated in the 
central nervous system by mechanisms involving selec-
tion, abstraction and synthesis of information from the 
total sensory input.48 The amount, quality and nature 
of the pain experienced are therefore dynamic and 
multidimensional products of sensory-discriminative, 
cognitive-evaluative and affective-motivational compo-
nents.48 Like any form of chronic pain, ongoing pain after 
surgery can lead to pathological nervous system changes, 
collectively known as sensitisation47—a function of what 
we now understand to be neuronal modifiability.46 Sensi-
tisation of the nervous system may lead to increased pain 
sensitivity (hyperalgesia), augmentation of the normal 
duration (hyperpathia) amplitude of pain, perception 
of non-painful stimuli as painful (allodynia)47 49 and 
abnormal, unpleasant hypersensitivity (dysesthesia).50
As Katz and Seltzer argued,32 critical to understanding 
the nature of CPSP is appreciating that in each case, the 
pain was once acute and involved a transition phase. 
There is much work to be done to continue to develop 
our understanding of risk factors, which predispose 
cardiac surgical patients to pain chronicity.
Prevalence and consequences
We reviewed 26 published/under review studies to date, 
across 14 countries,6–31 which have examined the prev-
alence and/or factors associated with CPSP following 
cardiac surgery. On careful examination of the available 
data, it is important to recognise that cross-sectional and 
retrospective studies have generally reported higher prev-
alence rates (14%–56%)%) than those investigations with 
prospective designs (7.5%–45%). In the recent (2013) 
large-scale Canadian CARDpain study (n=1010), Choin-
ière et al28 reported CPSP prevalence rates of 40%, 22% 
and 17% at 3, 6, and 12 months following cardiac surgery, 
respectively. Routledge et al31 found similar prevalence 
rates of CPSP in their prospective extension (Women’s 
Recovery from Sternotomy-Extension (WREST-E)) of a 
randomised clinical trial (Women’s Recovery from Ster-
notomy (WREST)) (n=222) to examine the impact of a 
novel compression undergarment on women’s recovery 
from median sternotomy (3 months postoperative [post-
op]: 41%; 12 months post-op: 16.7%). In contrast to 
CARDpain and WREST-E, 1 year CPSP prevalence rates as 
high as 39% and 45% have been reported in prospective 
studies of patients following CABG in Turkey27 and the 
Netherlands.30 Aside from differences in study design, the 
observed variability in reported prevalence rates of CPSP 
after cardiac surgery may be explained by the use of point 
prevalence versus cumulative prevalence, variability with 
respect to the operational definitions of CPSP, timing of 
outcome measurement and duration of follow-up period.
CPSP has been associated with the development of 
anxiety and depressive disorders,51–55 sleep disturbances 
and fatigue,56–60 as well as poor self-rated health.7 51 53 61 
For example, among those with CPSP in the CARDpain 
study, over 50% reported significant pain-related interfer-
ence with activities of daily living—including family and 
home responsibilities, recreation and employment—at 3, 
6 and 12 months following cardiac surgery.28 62
Risk factors for CPSP
Several studies have attempted to establish risk factors for 
CPSP in cardiac surgery patients.
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Their limitations can be summarised63 as: (1) many 
studies focused on univariate analyses, or were insuffi-
ciently powered to employ multivariate modelling tech-
niques, (2) the vast majority of risk factors examined 
to date are not tenably modifiable in the perioperative 
context, (3) psychological risk factors (affective and 
cognitive) are substantially understudied in comparison 
with demographic, clinical/surgical and analgesic risk 
factors, constituting a major gap and (4) although retro-
spective and cross-sectional studies provide some insight 
on potential variables associated with CPSP, cross-sec-
tional studies lack the temporal orientation to make solid 
inferences about putative, causal relationships and retro-
spective studies can be limited by availability and quality 
of data. In addition, even robust retrospective may be 
limited in terms of risk factors explored and related data 
collection methods. Risk factors for CPSP can be classi-
fied into four categories: (A) demographic, (B) baseline 
clinical, technical-surgical, and hospitalisation-related 
factors, (C) acute post-op pain and (D) psychological 
factors.
Demographic factors
Demographic factors examined include age, sex, level 
of education, body mass index (BMI) and smoking 
history. Younger age has been positively associated with 
CPSP7 9 12 17 20 25 28 in multiple retrospective, cross-sectional 
and prospective studies, as observational data embedded 
within randomised controlled trials (RCTs); significant 
ORs have ranged from 1.43 to 7.03 in cases where this 
outcome was dichotomised (ie, younger vs older patients). 
However, four of the more recent published studies to 
date (one retrospective,17one cross-sectional,18 one RCT50 
and one prospective21) have found no positive association 
between age and the development of CPSP. Conflicting 
findings have also been reported for sex. Although some 
studies indicate higher risk of CPSP with women,21 29 30 
multiple studies with divergent designs9 12 14 18 20 28 48 have 
reported no significant association between sex and the 
development of CPSP. Examination of BMI as a risk factor 
for CPSP has also produced mixed results. While two 
studies (one cross-sectional7 and one RCT [embedded 
observational data],20 ORs=1.34 and 9.05, respectively) 
provided supportive evidence, other cross- sectional17 18 
and prospective studies9 28 found no association between 
CPSP and BMI (OR range: 1.02–1.1). Finally, we are aware 
of two prospective studies to date that have examined the 
association of CPSP with formal level of education28 and 
smoking history,14 respectively; no significant association 
was found in either case.
Baseline clinical, surgical and hospitalisation-related factors
Among baseline clinical factors, neither a history of 
diabetes mellitus9 14 17 23 24 50 or peripheral arterial disease24 
have been significantly associated with the development 
of CPSP.
However, pre-existing peripheral arterial disease has 
been examined as a risk factor in just one retrospective 
study24 to date. Similar to diabetes mellitus, the majority of 
prospective studies20 21 23 (including one RCT)20 reported 
no predictive ability of baseline chronic pain condi-
tions in the literature (OR=1.00–1.04, where reported). 
To date, CARDpain28 is the only prospective examina-
tion to report that pre-existing chronic pain at baseline 
(non-anginal) is positively associated with CPSP (adjusted 
OR=1.44, 95% CI 1.12 to 1.86).28
The evidence pertaining to the predictive value of 
preoperative angina is also mixed. Two cross-sectional 
studies reported preoperative angina that was positively 
associated with CPSP (OR, where reported=1.62)7 12; 
however, another cross-sectional17 and two additional 
large-scale prospective studies14 28 found no significant 
associations to infer that preoperative angina is a signif-
icant risk factor for CPSP.
The majority of studies have reported no associ-
ation6 12 13 17 22 28 50 between a range of surgical factors, 
including: (A) type of surgical technique, (B) number 
and type of bypass grafts per operation, (C) harvesting 
technique and (D) total cross-clamp time (ie, total time 
aorta is clamped to separate systemic circulation from 
cardiac outflow) and the development of CPSP. There 
is some evidence to suggest that not skeletonising the 
internal thoracic artery harvest (ie, harvesting it along 
with its surrounding pedicle of vascular tissue) is more 
likely to invoke CPSP64; those who have undergone left 
IMA harvesting may also be at higher risk.13 42 In general, 
post-op complications and related adverse events (eg, 
reoperation for bleeding and infections) have not been 
associated with CPSP,9 12 14 16 20 28 with the exception of one 
prospective study that identified post-op resternotomy as 
a significant risk factor (OR=3.38).21 Cardiac surgeries 
of longer duration (ie, total OR time) 18 20 also do not 
seem predictive of CPSP; in fact, the CARDpain28 study 
found that the longer the OR time, the less likely CPSP 
was to develop. Finally, there seems to be no conclusive 
evidence to suggest that length of time in the intensive 
care unit,18 20 28 or total duration of hospitalisation18 
contribute to the development of CPSP after cardiac 
surgery.
Acute post-op pain
Two prospective studies found that severe pain (ie, 
numeric rating scale [NRS] ≥7/10) on post-op day 3 was a 
significant risk factor for CPSP at 1-year follow-up,21 as well 
as worst and average pain ratings at 2-year follow-up.28 A 
third prospective study found that severe pain on post-op 
day 30 positively predicted CPSP at 3 months.23 The asso-
ciation between analgesic therapy and CPSP is uncer-
tain.10–12 18 19 21 23 27 28
Psychological factors
Only the CARDpain28 study has examined the role of 
psychological risk factors in the development of CPSP 
and found that presurgical anxiety, as measured by the 
Hospital Anxiety and Depression Scale (HADS), was a 
significant risk factor, with a 10% increase in the odds of 
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developing CPSP for each unit increase in HADS-A scale 
scores (OR=1.10, 95% CI 1.06 to 1.14). Other psycholog-
ical risk factors examined (catastrophising and depres-
sion) demonstrated no association.
Genetic factors
Several members of this investigative team (eg, HC and 
JK) are involved in studies investigating the influence 
of genetic polymorphisms on the development of CPSP 
after cardiac and other types of surgery. The science of 
pain genetics is evolving; investigations of this nature are 
complex, requiring extensive research infrastructure for 
genotyping and related proteomic methods. Controlling 
for the influence of genetic factors is beyond the scope 
this study.
Conceptual underpinnings and study focus
To address the above noted gap in the research to date, our 
primary objective is to examine the potential influence of 
psychological factors on the development of CPSP after 
cardiac surgery. Clear justification for the specific puta-
tive risk factors to be measured requires that we first expli-
cate the conceptual underpinnings of our study. Given 
the complexity of the multidimensional pain experience, 
there are many ways to conceptualise CPSP.65 We are 
aligned with the biobehavioural view of pain, espoused by 
international leaders in the science of the cognitive and 
learning aspects of pain.65 66 Fundamental to the biobe-
havioural perspective is the assertion that people learn to 
predict future events based on prior learning experiences 
and information processing. As such, patients’ behaviours 
elicit responses from significant others, including health-
care professionals, which can reinforce both adaptive and 
maladaptive modes of thinking, feeling and behaving.65 
With this understanding, patients’ pain-related cogni-
tions and behaviours are of chief concern with respect to 
identifying factors that may contribute to the transition 
from acute post-op pain to chronic pain. In moving the 
science forward, we therefore give primacy to the cogni-
tive-behavioural side of the global biobehavioural view of 
pain, as the conceptual premise for our primary objec-
tive. According to the fundamental tenets of the cogni-
tive-behavioural perspective of pain65 66: (A) behaviour is 
reciprocally determined by the person and environment, 
(B) people can learn more adaptive ways of thinking and 
behaving and (C) people are capable of and should be 
involved as active agents in the change of maladaptive 
thoughts, amenable to intervention.65 Our focus there-
fore will be on the contribution of patients’ pain-related 
beliefs and expectations, as follows:
Pain-related beliefs
Decades of work9 67–82 in the fields of post-op pain and 
anaesthesia has demonstrated that surgical patients have 
beliefs about pain and pain medication, which: (A) are 
based on incorrect information and (B) serve to block 
effective pain assessment and management. For example, 
one study found that among patients undergoing CABG 
surgery (n=202), a majority (83%) reported that they 
would not voluntarily ask for pain medication when they 
needed it, although most reported unrelieved moder-
ate-to-severe pain from post-op day 2 (80%) until day 
5 (69%).67 As of 2013, data indicate that this unfortu-
nate scenario remains largely unchanged. Cogan et al82 
found that among cardiac surgery patients (n=564), 36% 
believed that ‘pain medication should be spared until the 
pain is very severe’, 20% believed that ‘good patients do 
not speak of their pain’ and 31% believed it is ‘very easy 
to become addicted to pain medication’ while recovering 
from surgery. The particular role of these beliefs per se 
in the development of CPSP has yet to be examined; we 
will do so in this study using the Pain Barriers Question-
naire (PBQ) (validated in multiple populations).
Gender-based pain expectations
As with a number of fields in the health sciences, the 
study of sex and gender, as they relate to pain, is evolving. 
Our comprehensive review of risk factors for CPSP after 
cardiac surgery revealed that, thus far, investigation has 
been limited to the contribution of sex only as a risk factor. 
For the purposes of this study, we employ the following 
distinctions between sex and gender, set forth by Lips,83 
which have been adopted in a number of well-cited pain 
studies84–99: sex: the biological distinction of being male or 
female; gender: learnt masculinity or femininity, related 
to socially-constructed roles and behaviours attributed to 
men and women in society.83 84
Emerging evidence suggests that gender-based pain 
expectations defined as ‘Sex-related stereotypic attribu-
tions about pain sensitivity, pain endurance, and willing-
ness to report pain’ 87 may lead to important differences 
in the experience of pain and related response. Robinson 
et al were among the first to investigate gender-based 
pain expectations, using the Gender Role Expectations 
of Pain Questionnaire (GREP).87 Their study of pain 
cognitions in 156 men and 235 women found that men 
were perceived to be less willing to report pain than 
women, women were perceived to be more sensitive and 
less enduring of pain than men and that men rated their 
pain endurance as higher than average. Further testing 
of the GREP by Wise et al94 found that after controlling 
for age, GREP scores accounted for 7%, 11% and 21% 
of the variance in pain threshold, tolerance and pain 
unpleasantness scores, respectively, for women (n=87) 
and men (n=61) exposed to thermal testing. A recent 
meta-analysis by Alabas et al,91 for example, examined 
the role of gender-related cognitions in the experience 
of pain.91 Pooling the results of six trials (406 men and 
539 women), they found that those who considered 
themselves more masculine and less sensitive to pain, 
than the typical man, exhibited higher pain thresholds 
and tolerances in a variety of settings. Using the GREP, 
our study will be the first we know of to examine the role 
of gender-based pain expectations on the development 
of CPSP after cardiac surgery.
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Health-related quality of life
Overwhelming evidence documents the deleterious 
impact of CPSP on health-related quality of life.6–31 50–62
Cost of illness
We will examine the impact of CPSP on patient-level cost, 
calculated from a societal perspective, wherein all costs 
irrespective of payer are included thereby comprising 
private and public costs, using the Ambulatory Home 
Care Record. Data are available that indicate that from 
20% to 30% of the occurrence of chronic pain is related to 
CPSP.98 99 Given the rates of cardiac surgery in Canada,4 5 
literature has shown that CPSP contributes substantially 
to the $22.2 billion in direct and indirect costs borne by 
cardiovascular interventions and services annually.15 With 
a view to comprehensive examination of the impact of 
CPSP, we will: (A) estimate the extra cost, expressed in 
healthcare costs, for patients with CPSP compared with 
those without and (B) estimate an incremental cost-ef-
fectiveness ratio, that is, the incremental cost for one 
additional quality-adjusted life year (QALY) gained, 
by virtue of cardiac surgery, among those who develop 
CPSP compared with those who do not. QALY is a pref-
erence-based utility measure of health-related quality of 
life as perceived by the patient.100 101 QALYs incorporate 
both length of life and quality of life into a single measure 
and are calculated by combining health- related quality 
of life measures with data on health state duration. As 
such, QALY is the gold standard measure of effectiveness 
recommended for economic evaluation and represents 
a universally comparable outcome measure. QALY will 
be derived from our Short Form-12 (SF-12) version 2 
(SF-12v2) data.
study objectives
Our primary objective is to examine the influence of 
pain-related beliefs and gender-based pain expectations 
on the development of chronic pain following cardiac 
surgery. Our secondary objectives are to: (A) examine the 
influence of pain-related beliefs and gender-based pain 
expectations on functional status and patient-level cost of 
illness following cardiac surgery; and (B) to determine 
the impact of CPSP on the QALY borne by cardiac surgery 
and the incremental cost for one additional QALY gained 
for patients, by virtue of cardiac surgery, among those 
who develop CPSP compared with those who do not.
MEthods And AnAlysIs
design
This study is a substudy of the Vascular Events In Surgery 
patIents cOhort evaluatioN - Cardiac Surgery study 
(https:// clinicaltrials. gov/ ct2/ show/ NCT01842568), 
examining 30-day all-cause mortality, myocardial injury 
and related complications following cardiac surgery 
in 15 000 participants. In this substudy, we propose 
to prospectively follow a cohort of patients who have 
undergone cardiac surgery for 1 year. Data on potential 
predictors will be collected at baseline. The total follow-up 
period is 12 months, with pain, functional status and cost 
of illness-related data being collected at 6 months and 12 
months following cardiac surgery.
Patient and public involvement
We collected patient testimonials to articulate the nature 
of the chronic pain problem following cardiac surgery 
from the patient perspective and establish the need for 
this study. Following the completion of the study, we will 
debrief the patient panel with the results of our findings.
study population
The target population of 1250 cardiac surgery patients 
will be recruited from participating hospital sites in 
Canada, USA and Hong Kong. Patients eligible for our 
study will be undergoing a first-time cardiac surgery 
involving a median sternotomy, including CABG and all 
open heart procedures, such as valvular repairs/replace-
ment. Eligible patients will also be able to read, speak 
and understand English and have a telephone allowing 
for follow-up. Patients will be ineligible if they: (A) have 
undergone previous cardiac surgery, thoracotomy or 
mastectomy, (B) are scheduled for an isolated pericardial 
window procedure (due to malignancy), pericardectomy, 
permanent pacemaker, or defibrillator implantation, (C) 
have a major cognitive disorder precluding participation, 
or (D) have a hearing impairment or speech impediment 
precluding telephone-based follow-up.
Cardiac surgery inpatients will be recruited in one of 
two ways: (1) from the hospital sites preoperative assess-
ment clinic, if their surgery is prebooked, or (2) from 
the cardiac surgical ward, if they have been admitted to 
hospital via the hospital’s emergency department or the 
heart investigation unit. A study nurse will obtain written, 
informed consent to participate among those willing and 
interested. The study enrolment period will conclude 
once the 1-year follow-up telephone interview is complete.
data collection
Immediately following enrolment, standard baseline 
demographic, independent variable data (participants’ 
age, sex, ethnicity, highest level of formal education, 
and marital and employment status) and data on base-
line covariates (age and sex) will be collected by the 
study nurse via interview and chart audit. Postopera-
tively, the study nurse will collect data on surgical details 
via chart audit, and data on post-op day 3 cumulative 
analgesic dose and pain intensity scores via chart audit 
and participant interview, respectively. The study nurse 
will contact patients by phone at 30 days, and 6 and 12 
months after surgery; the 30-day call will be for post-op 
pain monitoring, and the two subsequent calls will be for 
outcome assessment. Data on dependent variables will be 
measured at 6 months and 12 months following cardiac 
surgery. Table 1 outlines this visit schedule. The timing 
of this follow-up outcome measurement is in compliance 
with recommendations (2013) set forth by the Initiative 
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for Methods, Measurement, and Pain Assessment in Clin-
ical Trials to standardise the timing of outcome assess-
ment for prognostic studies of CPSP.102
dependent variables
Chronic postsurgical pain
The development of CPSP will be measured using a tele-
phone structured interview protocol, defined as pain: 
(A) that developed after the surgical procedure, (B) is 
different from pain experienced prior to the procedure 
(eg, preopeative angina), (C) is not caused by other 
factors (eg, cancer recurrence and chronic infection), 
(D) is present for at least 2–3 months and (E) that inter-
feres significantly with health-related quality of life.34–40
If participants answer in the affirmative to each of these 
questions, it will be indicated that ‘Yes’ they have developed 
CPSP; otherwise, it will be indicated that ‘No’ they have 
not. Among those deemed to have developed CPSP (ie, 
‘yes’) pain intensity, and its related interference with usual 
daily activities, will be measured via the Brief Pain Inven-
tory-Short Form (BPI-SF).103–107 The BPI-SF includes four 
11-point NRSs of pain intensity, which measure ‘average’, 
‘least’ and ‘worst’ pain intensity in the past 24 hours, respec-
tively, as well as pain intensity ‘now’ (0=no pain, 10=pain 
as bad as you can imagine). As is common to studies of 
CPSP28 29 62 67 108–113 (including cardiac surgery), participants 
will be asked for their ‘worst’ pain intensity rating both on 
rest and movement in the past 24 hours. The BPI-SF inter-
ference subscale103–107 will also be used, which measures the 
degree to which pain interferes with general activity, mood, 
walking, work, relations with others, sleep and enjoyment of 
life (NRS for each item; 0=does not interfere, 10=completely 
interferes). A total interference score is taken by calcu-
lating the sum of these seven items. The BPI-SF has strong 
psychometric properties with well-established reliability and 
validity across divergent surgical groups,29 103–117 including 
those reporting acute and chronic pain following cardiac 
surgery.28 29 62 67 112 113 The BPI-SF also contains supple-
mental items,103–106 for optional use (pain treatment and 
body diagram). Of these, only the body diagram will be 
used for descriptive purposes.
Functional status
Functional status will be measured with the SF-12v2), an 
established reliable and validated health status measure.118 
It consists of 12 items taken from the Short Form 36 
(SF-36), which is a widely accepted instrument that was 
developed from the Medical Outcomes Study.119–121 The 
SF-12v2 was developed to reduce respondent burden. It 
can be administered by telephone interview and consists 
of two scales that measure physical and mental health 
status. The SF-12v2 comprises eight domains, measured 
via eight subscales: (1) physical functioning; (2) role 
limitations due to physical problems; (3) role limitations 
due to emotional problems; (4) bodily pain; (5) general 
health; (6) vitality; (7) social functioning; and (8) mental 
health. Results may be expressed as physical component 
summary (PCS) and mental component summary scores. 
These scores range from 0 (worst) to 100 (best).118
Cost of illness
The Ambulatory and Home Care Record (AHCR)122–132 
will be used to measure patient-level cost of illness from 
a societal perspective. This approach gives equal consid-
eration to health system costs and costs borne by patients 
and unpaid caregivers, such as family members and 
friends. Items in the AHCR can be categorised as publicly 
financed care (ie, resources paid for by the public sector) 
or privately financed care (ie, all out-of-pocket payments, 
third party insurance payments and time costs incurred 
by caregiver). Face validity of the AHCR has been assessed 
by several healthcare providers, health economists and 
administrators who work in the field of ambulatory and 
home-based care.122 125 Reliability of the AHCR has been 
assessed via the level of agreement between self-reports of 
cost by cystic fibrosis care recipients and administrative 
data.125 Moderate to almost perfect agreement was found 
between study participants’ responses on the AHCR and 
administrative data (kappa=0.41–1.00).125 The AHCR 
has since been used to evaluate various conditions,124–132 
including chronic cardiology patients who were inter-
viewed over the phone131 132 Additionally, the AHCR has 
been used to assess costs for an array of patients, including 
Table 1 Visit schedule
Baseline Postoperative day 3 Day 30 6 months 1 year
Pain Barriers Questionnaire X
Gender-based pain expectations X
Somatic Pre-Occupation and Coping X
State-Trait Anxiety Inventory X
Hospital Anxiety and Depression Scale 
(HADS)
X
Short Form-12 (SF-12) X X X X
CPSP-related disability X X X
Analgesic chart audit X
Brief Pain Inventory X X X X
Ambulatory Home Care Record X X
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the elderly, middle-aged adults and children.122–132 The 
AHCR has been used in telephone and face-to-face inter-




Pain-related beliefs will be examined at baseline using 
the PBQ76 77 version II (PBQ-II)74 76–79 133 The PBQ-II134 
includes 27 items divided into four subscales: erroneous 
beliefs regarding secondary effects of medication (12 
items) and their harmful effects (six items), fatalism about 
the control of pain (three items) and attitudes regarding 
reporting pain to health professionals (six items). Each 
item is rated on a 0–5 scale (0: totally disagree; 5: totally 
agree). A total score and scores for each subscale can be 
calculated by taking the sum of the items. The PBQ-II has 
established validity, internal consistency and sensitivity to 
change113 135 136 and has recently been adapted and vali-
dated for use with cardiac surgical patients.113
Gender-based pain expectations
Gender-based pain expectations will be measured at base-
line using the GREP. The GREP87 measures stereotypic 
attributions regarding three constructs: pain endurance, 
pain sensitivity and willingness to report of pain. Each 
construct includes four 100 mm visual analogue scales 
regarding how women and men perceive themselves and 
the opposite sex, relative to: (A) their own sex and (B) the 
opposite sex with respect to how much pain can males/
females endure, how sensitive to pain males/females are 
and how willing males/females are to report pain; respon-
dents indicate their views on a 100 mm line anchored by 0 
(far less) and 100 (far more). An average score is derived 
for each construct; greater scores indicate more stereo-
typical views. The GREP has now been used in multiple 
pain investigations.87 89 91–93 137 138 Test–retest reliability 
is acceptable across items87 (0.53 to 0.93), and internal 
consistency reliability testing has demonstrated high 
correlations (−0.71 to −0.81) between individual items 
which assess opposite perceived gender roles (eg, typical 
masculine vs feminine orientation to pain endurance).87
Covariates
We will control for the following demographic, clinical 
and surgical covariates: sex, age, BMI, diabetes mellitus, 
peripheral arterial disease, preoperative chronic pain 
and angina (Canadian Cardiovascular Society class), 
non-skeletonised internal throacic artery harvest, re-ster-
notomy and operating time. Additional covariates include 
baseline functional status, anxiety and acute post-op pain.
Functional status
We will control for baseline functional status using the 
SF-12v2 PCS score.118
Baseline anxiety
We will control for anxiety at baseline using the Spiel-
berger State-Trait Anxiety Inventory (STAI), a widely used, 
well-validated anxiety measure.139 140 The STAI has 40 
items that comprise two domains: the State (STAI-S) and 
Trait (STAI-T) score, both ranging from 20 to 80, with 
higher scores representing higher levels of anxiety. The 
STAI-S measures the transitional emotional status evoked 
by a stressful situation, such as surgery. The STAI-T score 
reflects enduring individual differences in the likelihood 
of anxiety.141 The STAI has been found reliable and valid 
among patients undergoing cardiac surgery (Cronbach’s 
alpha=0.94)142 and is commonly applied in studies capturing 
preoperative anxiety among cardiac surgery patients.143 144
Acute post-op pain
Pain on post-op days 3 and 30 will be measured with the 
BPI. Cumulative 24 hours analgesic on post-op day 3, 
as an indication of analgesic dosing in hospital during 
recovery, will be determined via chart audit using a tool 
we have used in previous cardiac studies.28 62 67 Opioid 
dosage will be converted into parenteral morphine equiv-
alents per day using standard dosage tables.28 62 67
sample size
The primary analysis for this study is the association of 
pain-related beliefs and gender-based pain expectations 
with CPSP at 6 months and 12 months while adjusting for 
a number of prespecified covariates. Therefore, sample 
size was calculated based on the methods used by Hsieh 
and colleagues145 for multivariable logistic regression. In 
this validated method, the sample size for a simple logistic 
regression modelling a single independent variable X1 on 
the outcome is inflated by a variance inflation factor equal 
to 1 / (1-ρ2×2…xp), where ρ2×2…xp is equal to the propor-
tion of the variance of X1 explained by the regression 
relationship with X2…Xp.145 Additionally, sample size was 
inflated to account for the clustered nature of the data (ie, 
6-month and 12-month measurements) by incorporating 
an additional design effect equivalent to 1+ (m−1)*ρICC, 
where m is the number of measurements per cluster (ie, 
two time points) and ρICC represents the correlation 
of responses within clusters. A conservative scenario was 
assumed in which the correlation between the two follow-up 
measurements could be as high as 0.60, and the variance of 
the independent variables explained by covariates (ie, R2) 
was 0.16, resulting in a requirement of 1250 participants to 
detect a significant change in the odds of post-op pain of 
5% (ie, OR of 1.05). This calculation allows the prevalence 
of CPSP to be as low as 10% (as found in some previous 
studies). Should the prevalence of CPSP be higher, the 
correlation between measurements be smaller, or the vari-
ance explained in the independent variables be smaller, 
1250 participants will provide >80% power.145
data analyses
Categorical data (eg, presence or absence of CPSP at 6 
months and 1 year) will be summarised with frequen-
cies and proportions. Continuous data (eg, functional 
disability scores) will be evaluated for normality using 
Shapiro-Wilk tests of normality and summarised using 
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measures of central tendency and dispersion (eg, means 
and SD for normally distributed factors and medians and 
IQRs for non-normally distributed data). Generalised 
estimating equations (GEEs) will be used to model the 
primary analysis: the association between pain-related 
beliefs and gender-based pain expectations with the devel-
opment of CPSP at 6 months and 1 year while adjusting 
for prespecified covariates. GEE models account for 
the lack of independence in outcome measurements 
introduced by multiple measurements.146 We will enter 
all prespecified variables in the model and retain them 
throughout the analysis. For each model, the inclusion 
of an interaction term between the two independent vari-
ables of interest (pain belief scale and gender- based pain 
expectations) will be guided by 95% CIs and likelihood 
ratio significance tests. Model diagnostics will consist of 
influential observation examination and Breslow-Day 
tests for goodness of fit.147 148 We will also assess for multi-
collinearity in our model via assessment of condition 
indices.147 148
QALYs100 101 will be estimated by converting SF-12v2 
data collected in the study to utility score using a vali-
dated algorithm.149 After estimating QALYs, we will 
analyse it as a dependent variable using regression to esti-
mate the difference in expected QALYs between the two 
groups (ie, those with CPSP vs those without). In addi-
tion, after calculating total cost from the AHCR, we will 
analyse it as a dependent variable using regression to esti-
mate the difference in expected healthcare cost between 
the two groups (ie, patients with CPSP vs those without). 
Employing regression will allow for the adjustment of 
potential confounders. With a variety of different types 
of regression (ie, ordinary least squares and generalised 
linear models), we will explore the impact of various 
modelling assumptions. In addition, we will compare 
parametric and non-parametric CIs using bootstrapping. 
In theory, an ordinary least squares model produces 
unbiased estimates even if the data are skewed; however, 
different estimation methods (eg, generalised linear 
models) and different uncertainty methods (eg, non-para-
metric bootstrapping) will facilitate careful investiga-
tion of the impact that various assumptions have on our 
conclusions.150–153 The regression models will provide 
estimates of differences in QALYs and costs for partici-
pants who develop CPSP versus those who do not develop 
CPSP, which will allow us to calculate incremental cost for 
one QALY gained. A cost-effectiveness acceptability curve 
and 95% CI will be used to characterise the uncertainty 
of our findings.153
Ethics and dissemination
Both integrated and end-of-grant dissemination strat-
egies will be implemented. Study progress and results 
will be disseminated on CardiacPain.Net,154 a web-based 
pain resource centre (http:// cardiacpain. onlinecjc. ca/) 
linked to Elsevier’s global online readership, featuring 
active knowledge ‘push’ mechanisms including e-banner 
advertising and opt-in email blasts. Final results will be 
presented at international conferences and published in 
scientific journals.
Implications
CPSP is an important socioeconomic problem with 
well-documented deleterious consequences on func-
tional status for cardiac patients. We aim to investigate 
putative psychological risk factors that could be targeted 
for preventative intervention. We will also examine the 
economic consequences of CPSP comprehensively, 
including the impact on QALYs, with no additional data 
collection required. This study may contribute towards 
reducing the risk and impact of CPSP after cardiac 
surgery.
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